BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34211435)

  • 1. Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight.
    Diboun I; Ramanjaneya M; Ahmed L; Bashir M; Butler AE; Albagha O; Abou-Samra AB; Atkin SL; Mazloum NA; Elrayess MA
    Front Endocrinol (Lausanne); 2021; 12():638727. PubMed ID: 34211435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profiling of pre-gestational and gestational diabetes mellitus identifies novel predictors of pre-term delivery.
    Diboun I; Ramanjaneya M; Majeed Y; Ahmed L; Bashir M; Butler AE; Abou-Samra AB; Atkin SL; Mazloum NA; Elrayess MA
    J Transl Med; 2020 Sep; 18(1):366. PubMed ID: 32972433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
    Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
    J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
    Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
    Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome.
    Zhang Z; Hong Y; Chen M; Tan N; Liu S; Nie X; Zhou W
    Metabolomics; 2020 Jan; 16(2):20. PubMed ID: 31980950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q-Exactive based metabolomic study.
    Chen X; Lu T; Wang X; Sun X; Zhang J; Zhou K; Ji X; Sun R; Wang X; Chen M; Ling X
    Clin Chim Acta; 2020 Mar; 502():280-286. PubMed ID: 31758934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.
    Zhao X; Feng X; Zhao X; Jiang Y; Li X; Niu J; Meng X; Wu J; Xu G; Hou L; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():659268. PubMed ID: 34149613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry.
    Vonica CL; Ilie IR; Socaciu C; Moraru C; Georgescu B; Farcaş A; Roman G; Mureşan AA; Georgescu CE
    Scand J Clin Lab Invest; 2019 Oct; 79(6):437-442. PubMed ID: 31462125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers identification in follicular fluid in relation to live birth in in vitro fertilization of women with polycystic ovary syndrome in different subtypes by using UPLC-MS method.
    Liu X; Zhang C; Huang J; Liu H; Li B; Zhang F; Xu C
    Clin Chim Acta; 2024 Apr; 557():117860. PubMed ID: 38508572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
    Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
    J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels.
    Valdimarsdottir R; Wikström AK; Kallak TK; Elenis E; Axelsson O; Preissl H; Ubhayasekera SJKA; Bergquist J; Poromaa IS
    Reprod Biomed Online; 2021 Jan; 42(1):217-225. PubMed ID: 33077357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome.
    Tian Y; Zhang J; Li M; Shang J; Bai X; Zhang H; Wang Y; Chen H; Song X
    Front Endocrinol (Lausanne); 2023; 14():1077590. PubMed ID: 37065734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach.
    Dong F; Deng D; Chen H; Cheng W; Li Q; Luo R; Ding S
    Anal Bioanal Chem; 2015 Jun; 407(16):4683-95. PubMed ID: 25860656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Potential Biomarkers for Urine Metabolomics of Polycystic Ovary Syndrome Based on Gas Chromatography-Mass Spectrometry.
    Zou Y; Zhu FF; Fang CY; Xiong XY; Li HY
    Chin Med J (Engl); 2018 Apr; 131(8):945-949. PubMed ID: 29664055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic Insight into Polycystic Ovary Syndrome-An Overview.
    Rajska A; Buszewska-Forajta M; Rachoń D; Markuszewski MJ
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32659951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential biomarkers for clinical outcomes of IVF cycles in women with/without PCOS: Searching with metabolomics.
    Guan SY; Liu YY; Guo Y; Shen XX; Liu Y; Jin HX
    Front Endocrinol (Lausanne); 2022; 13():982200. PubMed ID: 36120473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: A pilot study.
    Ding Y; Jiang Y; Zhu M; Zhu Q; He Y; Lu Y; Wang Y; Qi J; Feng Y; Huang R; Yin H; Li S; Sun Y
    Front Endocrinol (Lausanne); 2022; 13():960274. PubMed ID: 36176459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels.
    Valdimarsdottir R; Valgeirsdottir H; Wikström AK; Kallak TK; Elenis E; Axelsson O; Ubhayasekhera K; Bergquist J; Piltonen TT; Pigny P; Giacobini P; Poromaa IS
    Reprod Biomed Online; 2019 Jul; 39(1):141-148. PubMed ID: 31036431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.